Faculty
-
August 13, 2014
On ABC News, Robert Klitzman Explores the Ethics of New Ebola Treatment
Although the World Health Organization has approved the new, experimental Ebola medication ZMapp, the limited supply of the drug raises questions about which patients should be prioritized for treatment.
ABC News said, "ZMapp...has notably not been supplied to the Africans who make up the majority of victims."
Bioethics director Robert Klitzman commented, "We want to make sure that we have clear criteria to make sure that it's done fairly."
Faculty
Sustainability education is crucial for preparing professionals to advance practical environmental solutions amid uncertainty.
Faculty
Explore books and recent publications from Columbia SPS Technology Management faculty on AI, leadership, cybersecurity, design, and more.
Faculty
M.S. in Bioethics Program Director Dr. Robert Klitzman speaks on the ethics of Dr. Craig Towers’ research and the importance of informed consent.
(ProPublica)
All News
